Tarsus Pharmaceuticals (TARS) EBITDA Margin (2021 - 2026)
Tarsus Pharmaceuticals' EBITDA Margin was -10.87% in Q2 2026, up 10.35 percentage points from -21.22% a year earlier but down 7.37 percentage points from the prior quarter.
Powered by 
Analysis
Tarsus Pharmaceuticals (TARS) EBITDA Margin (2021 - 2026) Analysis & Trends
On a trailing twelve-month basis, Tarsus Pharmaceuticals' EBITDA Margin was -7.62% through Jun 30, 2026, up 25.01 percentage points year-over-year; for FY2025, it was -15.30%, up 49.92 percentage points from FY2024.
- EBITDA Margin shows a four-year change of +5.47 percentage points (FY2021 to FY2025).
- In earlier years, EBITDA Margin was -65.22% in FY2024 (+750.28 pp), -815.50% in FY2023 (-573.84 pp), -241.66% in FY2022 (-220.89 pp) and -20.77% in FY2021.
- Quarterly EBITDA Margin has moved between -4262.72% (Q4 2021) and -3.51% (Q1 2026) over five years.
- Compared with a year earlier, EBITDA Margin has increased for eight straight quarters, with an average year-over-year change of +337.47 percentage points over the last eight quarters.
- The best year-over-year quarter for EBITDA Margin over five years was Q4 2022 (a gain of 4113.09 percentage points); the worst was Q1 2022 (a drop of 3646.34 percentage points).
- Per Business Quant data, TARS's EBITDA Margin in the three quarters before Q2 2026 was -3.51% (Q1 2026), -4.94% (Q4 2025) and -11.90% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | Tarsus Pharmaceuticals | 3.32 Bn | 2.27 Bn | 161.80 Mn | -10.87% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -10.87% |
| Mar 31, 2026 | -3.51% |
| Dec 31, 2025 | -4.94% |
| Sep 30, 2025 | -11.90% |
| Jun 30, 2025 | -21.22% |
| Mar 31, 2025 | -32.96% |
| Dec 31, 2024 | -36.11% |
| Sep 30, 2024 | -51.67% |
| Jun 30, 2024 | -81.11% |
| Mar 31, 2024 | -135.38% |
| Dec 31, 2023 | -337.30% |
| Sep 30, 2023 | -2,177.18% |
| Mar 31, 2023 | -993.92% |
| Dec 31, 2022 | -149.63% |
| Jun 30, 2022 | -33.59% |
| Mar 31, 2022 | -3,614.10% |
| Dec 31, 2021 | -4,262.72% |
| Sep 30, 2021 | -1,259.84% |
| Jun 30, 2021 | 33.64% |
| Mar 31, 2021 | 32.24% |
API Access
Tarsus Pharmaceuticals EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=TARS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "TARS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=TARS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();